Safety of percutaneous aortic valve insertion. A systematic review

Table 2 Data extracted from "presented series"

Registry acronym	Time window	n	Age	Logistic EuroSCORE	STS score	Success rate (%)	30-d mort	6-m mort	1-yr mort	Data source
Transfemoral Edwards Lifesciences PAVI
VANCOUVER	Jan 2005 - NA	114	84°	28°	9.1°	92.1	7.9	13**	20**	[39]
REVIVAL 2	Dec 2005 - Feb 2008	55	82.8 ± 6.8	34.1 ± 18.0	13.1 ± 7.2	87.3	7.3	16.6	24.2	[40, 41]
REVIVE 2	NA - Dec 2007	106	83.9 ± 5.4	29.9 ± 13.2	NA	88.0	13.2	21.4	28.6	[40, 41]
PARTNER EU	April 2007 - Jan 2008	60	82.5 ± 5.2	24.7 ± 11.7	10.9 ± 5.9	96.3	7.4	10	NA	[8]
SOURCE	Nov 2007 - Sep 2008	293	81.8	26.4	NA	97.7	6.4	NA	NA	[8]
Transfemoral CoreValve PAVI
CoreValve 21F S&E	Aug 2005 - 2006	52	81.4 ± 5.5	27.4 ± 15.1	NA	90.4	15.4	23**	35**	[2]
CoreValve 18F S&E	May 2006 - Oct 2007	124	81.8 ± 6.5	23.0 ± 13.5	NA	94.4	14.5	23**	28**	[2]
CoreValve 18F EE	April 2007 - Sep 2008	1243	81.2 ± 6.4	22.9 ± 14.1	NA	98.2	6.7	21°	NA	[2, 40]
TOTAL TRANSFEMORAL		2047					7.8
Transapical Edwards Lifesciences PAVI
VANCOUVER	Oct 2005 - NA	58	84°	28°	9.1°	98.3	19.0	34	34	[39]
REVIVAL 2	Dec 2005 - Feb 2008	40	83.7 ± 5.2	35.5 ± 15.3	13.4 ± 7.0	87.5	17.6	35.8	45.3	[3, 14]
TRAVERCE	Dec 2004 - April 2008	168	82.0 ± 5.6	26.9 ± 12.8	NA	92.9	14.9	30	35	[41]
PARTNER EU	April 2007 - Jan 2008	70	82.1 ± 5.7	33.5 ± 14.8	11.9 ± 7.0	91	18.6	42	NA	[8]
SOURCE	Nov 2007 - Sep 2008	309	80.7	30	NA	NA	11.6	NA	NA	[42]
TOTAL TRANSAPICAL		645					13.8

Registry acronyms: VANCOUVER: Vancouver single-centre experience; REVIVAL 2: peRcutaneous EndoVascular Implantation of VALves; REVIVE 2: Registry of EndoVascular Implantation of Valves in Europe; PARTNER EU: Placement of AoRTic TraNscathetER Valve Trial; SOURCE: edwards Sapien aOrtic bioprothesis eURropean outComE registry; CoreValve 21F S&E: 21 French safety and efficacy registry; CoreValve 18F S&E: 18 French safety and efficacy registry; CoreValve 18F EE: 18 French post CE mark Expanded Evaluation registry; TRAVERCE: TRAnsapical Surgical DeliVEry of the Cribier-Edwards aortic bioprosthesis. TF: transfemoral. TA: transapical. PAVI: percutaneous aortic valve insertion. *: 18 French and 21 French refer to the outer diameter of the delivery sheath. **: estimated from Kaplan Meier survival plot. °: data from TF and TA series combined.

ISSN: 1471-2261